| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |